Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Sep 21, 2021
| Bob Billings
Thank you, Kanu Patel
Press Release
Sep 21, 2021
| Rachel Schwartz
Study Finds U.S. Generic and Biosimilar Savings Totaled A Record $338 Billion in 2020
Press Release
Sep 13, 2021
| Rachel Schwartz
Polly Webster Joins AAM As Vice President, Federal Affairs
Press Release
Sep 13, 2021
| Rachel Schwartz
Scott Kuzner Joins AAM As Senior Director, Sciences and Regulatory Affairs
Press Release
Sep 9, 2021
| Rachel Schwartz
AAM Statement on HHS 45-Day Plan to Lower the Cost of Prescription Drugs
Blog
Sep 2, 2021
| Jewel Smith
Member Spotlight: Zydus USA
Video
Aug 30, 2021
| Erica Klinger
Join us a GRx+Biosims 2021 — Progress + Process
Blog
Aug 27, 2021
| Joanne Duncan
Our Team
Press Release
Aug 16, 2021
| Rachel Schwartz
AAM Calls for Increased Voluntary Licensing of Covid Vaccines to Increase Patient Access
Video
Aug 15, 2021
| Evan Chernicky
Akaimi's Story — Savings from Biosimilar Medicines
Press Release
Aug 12, 2021
| Rachel Schwartz
AAM Statement on President’s Build Back Better Plan
Press Release
Aug 10, 2021
| Rachel Schwartz
Joe Russo Joins AAM as Senior Director, Federal Government Affairs
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action